Methylprednisolone sodium succinate Chemical Properties

Melting point:

>186°C (dec.)

storage temp. 

Inert atmosphere,Room Temperature

solubility 

DMSO (Slightly), Methanol (Slightly)

form 

lyophilized powder

color 

White to Off-White

InChIKey

FQISKWAFAHGMGT-JXAFMBTDNA-M

SMILES

[C@]12(C[C@@H](C3=CC(=O)C=C[C@]3(C)[C@@]1([H])[C@H](C[C@]1(C)[C@@](CC[C@@]21[H])(O)C(=O)COC(=O)CCC([O-])=O)O)C)[H].[Na+] |&1:0,2,9,11,13,15,17,20,r|

CAS DataBase Reference

2375-03-3(CAS DataBase Reference)

Safety Information

Hazard Codes 

T

Risk Statements 

61-40

Safety Statements 

53-22-36/37/39-45

WGK Germany 

3

RTECS 

TU4154060

Toxicity

LD50 oral in rat: > 5gm/kg

Methylprednisolone sodium succinate Usage And Synthesis

Description

Methylprednisolone Sodium Succinate is the sodium succinate salt of a synthetic glucocorticoid receptor agonist with immunosuppressive and anti-inflammatory effects. It is converted into active prednisolone in the body, which activates glucocorticoid receptor-mediated gene expression. This includes inducing the synthesis of the anti-inflammatory protein IkappaB-alpha and inhibiting the synthesis of nuclear factor kappa B (NF-kappaB). As a result, proinflammatory cytokine production, such as IL-1, IL-2, and IL-6, is down-regulated, and cytotoxic T-lymphocyte activation is inhibited. Therefore, an overall reduction in chronic inflammation and autoimmune reactions may be achieved.

Uses

6α-Methylprednisolone 21-Hemisuccinate is a glucocorticosteroid used in anti-inflammatory medication in the treatment of spinal cord injuries.

Uses

6α-methylprednisolone 21-hemisuccinate sodium salt has been used to investigate glucocorticoid-induced osteonecrosis under hypoxic conditions in the MC3T3-E1 osteoblast cell line using a cell cytotoxicity assay, flow cytometry and western blotting.

Definition

ChEBI: Methylprednisolone sodium succinate is a corticosteroid hormone.

brand name

A-Methapred (Abbott); A-Methapred (Hospira); Solu-Medrol (Pharmacia & Upjohn).

Biochem/physiol Actions

Glucocorticoid with slightly longer half-life than that of prednisolone.

Side effects

Methylprednisolone Sodium Succinate is commonly given by injection and common side effects include: injection site pain/redness/swelling, nausea, vomiting, heartburn, headache, dizziness, difficulty sleeping, appetite changes, increased sweating, acne, increased blood sugar, sore throat, fever, chills, cough, white spots in the mouth. Serious side effects manifest as abnormal weight gain, menstrual disorders, bone/joint pain, easy bruising/bleeding, mental/mood changes, fast/slow/irregular heartbeat, stomach/intestinal bleeding symptoms, seizures, liver problems, and symptoms of severe allergic reactions. Contact your doctor if any of these serious adverse symptoms occur.

Methylprednisolone sodium succinate(2375-03-3)Related Product Information

• Kresoxim-methyl
• Trisodium phosphate
• Sodium acetate
• Thiophanate-methyl
• Methylprednisolone acetate
• Bensulfuron methyl
• Sodium bicarbonate
• Methyl acrylate
• Prednisolone-21-acetate
• Sodium benzoate
• Methylparaben
• Diclofenac sodium
• Sodium hydroxide
• Sodium chloride
• Methylprednisolone
• Hydrocortisone sodium succinate
• Prednisolone
• Disodium succinate